| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.72B | 48.46B | 44.39B | 41.50B | 33.27B | 29.38B |
| Gross Profit | 28.35B | 27.90B | 25.04B | 24.21B | 20.63B | 17.92B |
| EBITDA | 4.77B | 6.74B | 3.19B | 12.86B | 2.02B | 1.40B |
| Net Income | 3.74B | 3.60B | 1.09B | 8.61B | 1.37B | 185.90M |
Balance Sheet | ||||||
| Total Assets | 44.01B | 46.49B | 45.50B | 41.64B | 28.88B | 25.77B |
| Cash, Cash Equivalents and Short-Term Investments | 15.62B | 14.26B | 10.70B | 9.05B | 4.72B | 4.06B |
| Total Debt | 3.61B | 7.67B | 9.69B | 6.56B | 8.81B | 10.09B |
| Total Liabilities | 25.56B | 27.03B | 28.03B | 25.87B | 22.68B | 21.43B |
| Stockholders Equity | 18.45B | 19.45B | 17.47B | 15.77B | 6.20B | 4.34B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.09B | -954.62M | 7.12B | 2.19B | 377.59M |
| Operating Cash Flow | 0.00 | 5.74B | -74.37M | 8.41B | 2.54B | 913.11M |
| Investing Cash Flow | 0.00 | 2.88B | -967.43M | -1.45B | -423.31M | -542.79M |
| Financing Cash Flow | 0.00 | -5.44B | 2.58B | -4.25B | -1.62B | 782.77M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥44.33B | 16.56 | ― | 4.61% | 0.63% | -24.87% | |
81 Outperform | ¥22.40B | 6.01 | 21.29% | 0.96% | 7.81% | 301.96% | |
80 Outperform | ¥32.12B | 8.40 | ― | 2.41% | 16.42% | 79.16% | |
74 Outperform | ¥46.29B | 20.35 | ― | 2.57% | -1.19% | -30.24% | |
73 Outperform | $72.68B | 10.17 | 9.51% | 3.37% | 5.32% | 106.88% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |